Industry Research Reports

Home > Reports > Pharma & Healthcare > Pet NSAIDs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Pet NSAIDs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Pharma & Healthcare

Published Date: 2024-01-11

Pages: 144 Pages

Report ld: 2634892

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Pet NSAIDs Market Size(US$)

CAGR 2024-2030

4.1%

Market Size,2030

USD 48

Million

Market Snapshot

Market Size in 2024 (Value)

US$ 38 million

Market Forecast in 2030(Value)

US$ 48 million

CAGR

4.1%

Years Considered

2019-2030

Base Year

2024

Forecast Period

2024-2030

Source: Secondary research, interviews with experts, and QYResearch analysis

Pet Non-steroidal anti-inflammatory drugs (NSAIDs) are medicines that are widely used to relieve pain, reduce inflammation, and bring down a high temperature. They can relieve the pain caused by inflammation of the pet's knee joint.

The global market for Pet NSAIDs was estimated to be worth US$ 35 million in 2023 and is forecast to a readjusted size of US$ 48 million by 2030 with a CAGR of 4.1% during the forecast period 2024-2030

Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 46%.

MARKET SEGMENTATION

By Company

Zoetis
Elanco
PREVICOX
Metacam
Chanelle Pharma
AVENTIX
Woodruff
KRKA UK Ltd
Dechra
Parnell
VetUK
Norbrook
Alivira Animal Health
Vedco Inc
Vethical
Vetoquinol
Pivetal

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Carprofen
Deracoxib
Firocoxib
Meloxicam

Segment by Application

Dog
Cat
Horse
Others

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for Pet NSAIDs, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Pet NSAIDs by region & country, by Type, and by Application.

The Pet NSAIDs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet NSAIDs.

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Pet NSAIDs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Pet NSAIDs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Pet NSAIDs in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Pet NSAIDs Product Introduction

1.2 Global Pet NSAIDs Market Size Forecast

1.2.1 Global Pet NSAIDs Sales Value (2019-2030)

1.2.2 Global Pet NSAIDs Sales Volume (2019-2030)

1.2.3 Global Pet NSAIDs Sales Price (2019-2030)

1.3 Pet NSAIDs Market Trends & Drivers

1.3.1 Pet NSAIDs Industry Trends

1.3.2 Pet NSAIDs Market Drivers & Opportunity

1.3.3 Pet NSAIDs Market Challenges

1.3.4 Pet NSAIDs Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Pet NSAIDs Players Revenue Ranking (2023)

2.2 Global Pet NSAIDs Revenue by Company (2019-2024)

2.3 Global Pet NSAIDs Players Sales Volume Ranking (2023)

2.4 Global Pet NSAIDs Sales Volume by Company Players (2019-2024)

2.5 Global Pet NSAIDs Average Price by Company (2019-2024)

2.6 Key Manufacturers Pet NSAIDs Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Pet NSAIDs Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Pet NSAIDs

2.9 Pet NSAIDs Market Competitive Analysis

2.9.1 Pet NSAIDs Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Pet NSAIDs Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet NSAIDs as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Carprofen

3.1.2 Deracoxib

3.1.3 Firocoxib

3.1.4 Meloxicam

3.2 Global Pet NSAIDs Sales Value by Type

3.2.1 Global Pet NSAIDs Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Pet NSAIDs Sales Value, by Type (2019-2030)

3.2.3 Global Pet NSAIDs Sales Value, by Type (%) (2019-2030)

3.3 Global Pet NSAIDs Sales Volume by Type

3.3.1 Global Pet NSAIDs Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Pet NSAIDs Sales Volume, by Type (2019-2030)

3.3.3 Global Pet NSAIDs Sales Volume, by Type (%) (2019-2030)

3.4 Global Pet NSAIDs Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Dog

4.1.2 Cat

4.1.3 Horse

4.1.4 Others

4.2 Global Pet NSAIDs Sales Value by Application

4.2.1 Global Pet NSAIDs Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Pet NSAIDs Sales Value, by Application (2019-2030)

4.2.3 Global Pet NSAIDs Sales Value, by Application (%) (2019-2030)

4.3 Global Pet NSAIDs Sales Volume by Application

4.3.1 Global Pet NSAIDs Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Pet NSAIDs Sales Volume, by Application (2019-2030)

4.3.3 Global Pet NSAIDs Sales Volume, by Application (%) (2019-2030)

4.4 Global Pet NSAIDs Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Pet NSAIDs Sales Value by Region

5.1.1 Global Pet NSAIDs Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Pet NSAIDs Sales Value by Region (2019-2024)

5.1.3 Global Pet NSAIDs Sales Value by Region (2025-2030)

5.1.4 Global Pet NSAIDs Sales Value by Region (%), (2019-2030)

5.2 Global Pet NSAIDs Sales Volume by Region

5.2.1 Global Pet NSAIDs Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Pet NSAIDs Sales Volume by Region (2019-2024)

5.2.3 Global Pet NSAIDs Sales Volume by Region (2025-2030)

5.2.4 Global Pet NSAIDs Sales Volume by Region (%), (2019-2030)

5.3 Global Pet NSAIDs Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Pet NSAIDs Sales Value, 2019-2030

5.4.2 North America Pet NSAIDs Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Pet NSAIDs Sales Value, 2019-2030

5.5.2 Europe Pet NSAIDs Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Pet NSAIDs Sales Value, 2019-2030

5.6.2 Asia Pacific Pet NSAIDs Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Pet NSAIDs Sales Value, 2019-2030

5.7.2 South America Pet NSAIDs Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Pet NSAIDs Sales Value, 2019-2030

5.8.2 Middle East & Africa Pet NSAIDs Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Pet NSAIDs Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Pet NSAIDs Sales Value

6.2.1 Key Countries/Regions Pet NSAIDs Sales Value, 2019-2030

6.2.2 Key Countries/Regions Pet NSAIDs Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Pet NSAIDs Sales Value, 2019-2030

6.3.2 United States Pet NSAIDs Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Pet NSAIDs Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Pet NSAIDs Sales Value, 2019-2030

6.4.2 Europe Pet NSAIDs Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Pet NSAIDs Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Pet NSAIDs Sales Value, 2019-2030

6.5.2 China Pet NSAIDs Sales Value by Type (%), 2023 VS 2030

6.5.3 China Pet NSAIDs Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Pet NSAIDs Sales Value, 2019-2030

6.6.2 Japan Pet NSAIDs Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Pet NSAIDs Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Pet NSAIDs Sales Value, 2019-2030

6.7.2 South Korea Pet NSAIDs Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Pet NSAIDs Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Pet NSAIDs Sales Value, 2019-2030

6.8.2 Southeast Asia Pet NSAIDs Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Pet NSAIDs Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Pet NSAIDs Sales Value, 2019-2030

6.9.2 India Pet NSAIDs Sales Value by Type (%), 2023 VS 2030

6.9.3 India Pet NSAIDs Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Zoetis

7.1.1 Zoetis Company Information

7.1.2 Zoetis Introduction and Business Overview

7.1.3 Zoetis Pet NSAIDs Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Zoetis Pet NSAIDs Product Offerings

7.1.5 Zoetis Recent Development

7.2 Elanco

7.2.1 Elanco Company Information

7.2.2 Elanco Introduction and Business Overview

7.2.3 Elanco Pet NSAIDs Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Elanco Pet NSAIDs Product Offerings

7.2.5 Elanco Recent Development

7.3 PREVICOX

7.3.1 PREVICOX Company Information

7.3.2 PREVICOX Introduction and Business Overview

7.3.3 PREVICOX Pet NSAIDs Sales, Revenue and Gross Margin (2019-2024)

7.3.4 PREVICOX Pet NSAIDs Product Offerings

7.3.5 PREVICOX Recent Development

7.4 Metacam

7.4.1 Metacam Company Information

7.4.2 Metacam Introduction and Business Overview

7.4.3 Metacam Pet NSAIDs Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Metacam Pet NSAIDs Product Offerings

7.4.5 Metacam Recent Development

7.5 Chanelle Pharma

7.5.1 Chanelle Pharma Company Information

7.5.2 Chanelle Pharma Introduction and Business Overview

7.5.3 Chanelle Pharma Pet NSAIDs Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Chanelle Pharma Pet NSAIDs Product Offerings

7.5.5 Chanelle Pharma Recent Development

7.6 AVENTIX

7.6.1 AVENTIX Company Information

7.6.2 AVENTIX Introduction and Business Overview

7.6.3 AVENTIX Pet NSAIDs Sales, Revenue and Gross Margin (2019-2024)

7.6.4 AVENTIX Pet NSAIDs Product Offerings

7.6.5 AVENTIX Recent Development

7.7 Woodruff

7.7.1 Woodruff Company Information

7.7.2 Woodruff Introduction and Business Overview

7.7.3 Woodruff Pet NSAIDs Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Woodruff Pet NSAIDs Product Offerings

7.7.5 Woodruff Recent Development

7.8 KRKA UK Ltd

7.8.1 KRKA UK Ltd Company Information

7.8.2 KRKA UK Ltd Introduction and Business Overview

7.8.3 KRKA UK Ltd Pet NSAIDs Sales, Revenue and Gross Margin (2019-2024)

7.8.4 KRKA UK Ltd Pet NSAIDs Product Offerings

7.8.5 KRKA UK Ltd Recent Development

7.9 Dechra

7.9.1 Dechra Company Information

7.9.2 Dechra Introduction and Business Overview

7.9.3 Dechra Pet NSAIDs Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Dechra Pet NSAIDs Product Offerings

7.9.5 Dechra Recent Development

7.10 Parnell

7.10.1 Parnell Company Information

7.10.2 Parnell Introduction and Business Overview

7.10.3 Parnell Pet NSAIDs Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Parnell Pet NSAIDs Product Offerings

7.10.5 Parnell Recent Development

7.11 VetUK

7.11.1 VetUK Company Information

7.11.2 VetUK Introduction and Business Overview

7.11.3 VetUK Pet NSAIDs Sales, Revenue and Gross Margin (2019-2024)

7.11.4 VetUK Pet NSAIDs Product Offerings

7.11.5 VetUK Recent Development

7.12 Norbrook

7.12.1 Norbrook Company Information

7.12.2 Norbrook Introduction and Business Overview

7.12.3 Norbrook Pet NSAIDs Sales, Revenue and Gross Margin (2019-2024)

7.12.4 Norbrook Pet NSAIDs Product Offerings

7.12.5 Norbrook Recent Development

7.13 Alivira Animal Health

7.13.1 Alivira Animal Health Company Information

7.13.2 Alivira Animal Health Introduction and Business Overview

7.13.3 Alivira Animal Health Pet NSAIDs Sales, Revenue and Gross Margin (2019-2024)

7.13.4 Alivira Animal Health Pet NSAIDs Product Offerings

7.13.5 Alivira Animal Health Recent Development

7.14 Vedco Inc

7.14.1 Vedco Inc Company Information

7.14.2 Vedco Inc Introduction and Business Overview

7.14.3 Vedco Inc Pet NSAIDs Sales, Revenue and Gross Margin (2019-2024)

7.14.4 Vedco Inc Pet NSAIDs Product Offerings

7.14.5 Vedco Inc Recent Development

7.15 Vethical

7.15.1 Vethical Company Information

7.15.2 Vethical Introduction and Business Overview

7.15.3 Vethical Pet NSAIDs Sales, Revenue and Gross Margin (2019-2024)

7.15.4 Vethical Pet NSAIDs Product Offerings

7.15.5 Vethical Recent Development

7.16 Vetoquinol

7.16.1 Vetoquinol Company Information

7.16.2 Vetoquinol Introduction and Business Overview

7.16.3 Vetoquinol Pet NSAIDs Sales, Revenue and Gross Margin (2019-2024)

7.16.4 Vetoquinol Pet NSAIDs Product Offerings

7.16.5 Vetoquinol Recent Development

7.17 Pivetal

7.17.1 Pivetal Company Information

7.17.2 Pivetal Introduction and Business Overview

7.17.3 Pivetal Pet NSAIDs Sales, Revenue and Gross Margin (2019-2024)

7.17.4 Pivetal Pet NSAIDs Product Offerings

7.17.5 Pivetal Recent Development

8 Industry Chain Analysis

8.1 Pet NSAIDs Industrial Chain

8.2 Pet NSAIDs Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Pet NSAIDs Sales Model

8.5.2 Sales Channel

8.5.3 Pet NSAIDs Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Pet NSAIDs Market Trends

Table 2. Pet NSAIDs Market Drivers & Opportunity

Table 3. Pet NSAIDs Market Challenges

Table 4. Pet NSAIDs Market Restraints

Table 5. Global Pet NSAIDs Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Pet NSAIDs Revenue Market Share by Company (2019-2024)

Table 7. Global Pet NSAIDs Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Pet NSAIDs Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Pet NSAIDs Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers Pet NSAIDs Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Pet NSAIDs Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Pet NSAIDs

Table 13. Global Pet NSAIDs Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet NSAIDs as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Pet NSAIDs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Pet NSAIDs Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Pet NSAIDs Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Pet NSAIDs Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Pet NSAIDs Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Pet NSAIDs Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Pet NSAIDs Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Pet NSAIDs Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Pet NSAIDs Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Pet NSAIDs Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Pet NSAIDs Price by Type (2019-2024) & (US$/Unit)

Table 27. Global Pet NSAIDs Price by Type (2025-2030) & (US$/Unit)

Table 28. Global Pet NSAIDs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Pet NSAIDs Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Pet NSAIDs Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Pet NSAIDs Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Pet NSAIDs Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Pet NSAIDs Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Pet NSAIDs Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Pet NSAIDs Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Pet NSAIDs Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Pet NSAIDs Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Pet NSAIDs Price by Application (2019-2024) & (US$/Unit)

Table 39. Global Pet NSAIDs Price by Application (2025-2030) & (US$/Unit)

Table 40. Global Pet NSAIDs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Pet NSAIDs Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Pet NSAIDs Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Pet NSAIDs Sales Value by Region (2019-2024) & (%)

Table 44. Global Pet NSAIDs Sales Value by Region (2025-2030) & (%)

Table 45. Global Pet NSAIDs Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Pet NSAIDs Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Pet NSAIDs Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Pet NSAIDs Sales Volume by Region (2019-2024) & (%)

Table 49. Global Pet NSAIDs Sales Volume by Region (2025-2030) & (%)

Table 50. Global Pet NSAIDs Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global Pet NSAIDs Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions Pet NSAIDs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Pet NSAIDs Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Pet NSAIDs Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Pet NSAIDs Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Pet NSAIDs Sales Volume, (2025-2030) & (K Units)

Table 57. Zoetis Company Information

Table 58. Zoetis Introduction and Business Overview

Table 59. Zoetis Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. Zoetis Pet NSAIDs Product Offerings

Table 61. Zoetis Recent Development

Table 62. Elanco Company Information

Table 63. Elanco Introduction and Business Overview

Table 64. Elanco Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. Elanco Pet NSAIDs Product Offerings

Table 66. Elanco Recent Development

Table 67. PREVICOX Company Information

Table 68. PREVICOX Introduction and Business Overview

Table 69. PREVICOX Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. PREVICOX Pet NSAIDs Product Offerings

Table 71. PREVICOX Recent Development

Table 72. Metacam Company Information

Table 73. Metacam Introduction and Business Overview

Table 74. Metacam Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. Metacam Pet NSAIDs Product Offerings

Table 76. Metacam Recent Development

Table 77. Chanelle Pharma Company Information

Table 78. Chanelle Pharma Introduction and Business Overview

Table 79. Chanelle Pharma Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 80. Chanelle Pharma Pet NSAIDs Product Offerings

Table 81. Chanelle Pharma Recent Development

Table 82. AVENTIX Company Information

Table 83. AVENTIX Introduction and Business Overview

Table 84. AVENTIX Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 85. AVENTIX Pet NSAIDs Product Offerings

Table 86. AVENTIX Recent Development

Table 87. Woodruff Company Information

Table 88. Woodruff Introduction and Business Overview

Table 89. Woodruff Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 90. Woodruff Pet NSAIDs Product Offerings

Table 91. Woodruff Recent Development

Table 92. KRKA UK Ltd Company Information

Table 93. KRKA UK Ltd Introduction and Business Overview

Table 94. KRKA UK Ltd Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 95. KRKA UK Ltd Pet NSAIDs Product Offerings

Table 96. KRKA UK Ltd Recent Development

Table 97. Dechra Company Information

Table 98. Dechra Introduction and Business Overview

Table 99. Dechra Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 100. Dechra Pet NSAIDs Product Offerings

Table 101. Dechra Recent Development

Table 102. Parnell Company Information

Table 103. Parnell Introduction and Business Overview

Table 104. Parnell Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 105. Parnell Pet NSAIDs Product Offerings

Table 106. Parnell Recent Development

Table 107. VetUK Company Information

Table 108. VetUK Introduction and Business Overview

Table 109. VetUK Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 110. VetUK Pet NSAIDs Product Offerings

Table 111. VetUK Recent Development

Table 112. Norbrook Company Information

Table 113. Norbrook Introduction and Business Overview

Table 114. Norbrook Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 115. Norbrook Pet NSAIDs Product Offerings

Table 116. Norbrook Recent Development

Table 117. Alivira Animal Health Company Information

Table 118. Alivira Animal Health Introduction and Business Overview

Table 119. Alivira Animal Health Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 120. Alivira Animal Health Pet NSAIDs Product Offerings

Table 121. Alivira Animal Health Recent Development

Table 122. Vedco Inc Company Information

Table 123. Vedco Inc Introduction and Business Overview

Table 124. Vedco Inc Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 125. Vedco Inc Pet NSAIDs Product Offerings

Table 126. Vedco Inc Recent Development

Table 127. Vethical Company Information

Table 128. Vethical Introduction and Business Overview

Table 129. Vethical Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 130. Vethical Pet NSAIDs Product Offerings

Table 131. Vethical Recent Development

Table 132. Vetoquinol Company Information

Table 133. Vetoquinol Introduction and Business Overview

Table 134. Vetoquinol Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 135. Vetoquinol Pet NSAIDs Product Offerings

Table 136. Vetoquinol Recent Development

Table 137. Pivetal Company Information

Table 138. Pivetal Introduction and Business Overview

Table 139. Pivetal Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 140. Pivetal Pet NSAIDs Product Offerings

Table 141. Pivetal Recent Development

Table 142. Key Raw Materials Lists

Table 143. Raw Materials Key Suppliers Lists

Table 144. Pet NSAIDs Downstream Customers

Table 145. Pet NSAIDs Distributors List

Table 146. Research Programs/Design for This Report

Table 147. Key Data Information from Secondary Sources

Table 148. Key Data Information from Primary Sources

List of Figures

Figure 1. Pet NSAIDs Product Picture

Figure 2. Global Pet NSAIDs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Pet NSAIDs Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Pet NSAIDs Sales Volume (2019-2030) & (K Units)

Figure 5. Global Pet NSAIDs Sales Price (2019-2030) & (US$/Unit)

Figure 6. Pet NSAIDs Report Years Considered

Figure 7. Global Pet NSAIDs Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Pet NSAIDs Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Pet NSAIDs Revenue in 2023

Figure 10. Pet NSAIDs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Carprofen Picture

Figure 12. Deracoxib Picture

Figure 13. Firocoxib Picture

Figure 14. Meloxicam Picture

Figure 15. Global Pet NSAIDs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 16. Global Pet NSAIDs Sales Value Market Share by Type, 2023 & 2030

Figure 17. Global Pet NSAIDs Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 18. Global Pet NSAIDs Sales Volume Market Share by Type, 2023 & 2030

Figure 19. Global Pet NSAIDs Price by Type (2019-2030) & (US$/Unit)

Figure 20. Product Picture of Dog

Figure 21. Product Picture of Cat

Figure 22. Product Picture of Horse

Figure 23. Product Picture of Others

Figure 24. Global Pet NSAIDs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 25. Global Pet NSAIDs Sales Value Market Share by Application, 2023 & 2030

Figure 26. Global Pet NSAIDs Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 27. Global Pet NSAIDs Sales Volume Market Share by Application, 2023 & 2030

Figure 28. Global Pet NSAIDs Price by Application (2019-2030) & (US$/Unit)

Figure 29. North America Pet NSAIDs Sales Value (2019-2030) & (US$ Million)

Figure 30. North America Pet NSAIDs Sales Value by Country (%), 2023 VS 2030

Figure 31. Europe Pet NSAIDs Sales Value (2019-2030) & (US$ Million)

Figure 32. Europe Pet NSAIDs Sales Value by Country (%), 2023 VS 2030

Figure 33. Asia Pacific Pet NSAIDs Sales Value (2019-2030) & (US$ Million)

Figure 34. Asia Pacific Pet NSAIDs Sales Value by Country (%), 2023 VS 2030

Figure 35. South America Pet NSAIDs Sales Value (2019-2030) & (US$ Million)

Figure 36. South America Pet NSAIDs Sales Value by Country (%), 2023 VS 2030

Figure 37. Middle East & Africa Pet NSAIDs Sales Value (2019-2030) & (US$ Million)

Figure 38. Middle East & Africa Pet NSAIDs Sales Value by Country (%), 2023 VS 2030

Figure 39. Key Countries/Regions Pet NSAIDs Sales Value (%), (2019-2030)

Figure 40. Key Countries/Regions Pet NSAIDs Sales Volume (%), (2019-2030)

Figure 41. United States Pet NSAIDs Sales Value, (2019-2030) & (US$ Million)

Figure 42. United States Pet NSAIDs Sales Value by Type (%), 2023 VS 2030

Figure 43. United States Pet NSAIDs Sales Value by Application (%), 2023 VS 2030

Figure 44. Europe Pet NSAIDs Sales Value, (2019-2030) & (US$ Million)

Figure 45. Europe Pet NSAIDs Sales Value by Type (%), 2023 VS 2030

Figure 46. Europe Pet NSAIDs Sales Value by Application (%), 2023 VS 2030

Figure 47. China Pet NSAIDs Sales Value, (2019-2030) & (US$ Million)

Figure 48. China Pet NSAIDs Sales Value by Type (%), 2023 VS 2030

Figure 49. China Pet NSAIDs Sales Value by Application (%), 2023 VS 2030

Figure 50. Japan Pet NSAIDs Sales Value, (2019-2030) & (US$ Million)

Figure 51. Japan Pet NSAIDs Sales Value by Type (%), 2023 VS 2030

Figure 52. Japan Pet NSAIDs Sales Value by Application (%), 2023 VS 2030

Figure 53. South Korea Pet NSAIDs Sales Value, (2019-2030) & (US$ Million)

Figure 54. South Korea Pet NSAIDs Sales Value by Type (%), 2023 VS 2030

Figure 55. South Korea Pet NSAIDs Sales Value by Application (%), 2023 VS 2030

Figure 56. Southeast Asia Pet NSAIDs Sales Value, (2019-2030) & (US$ Million)

Figure 57. Southeast Asia Pet NSAIDs Sales Value by Type (%), 2023 VS 2030

Figure 58. Southeast Asia Pet NSAIDs Sales Value by Application (%), 2023 VS 2030

Figure 59. India Pet NSAIDs Sales Value, (2019-2030) & (US$ Million)

Figure 60. India Pet NSAIDs Sales Value by Type (%), 2023 VS 2030

Figure 61. India Pet NSAIDs Sales Value by Application (%), 2023 VS 2030

Figure 62. Pet NSAIDs Industrial Chain

Figure 63. Pet NSAIDs Manufacturing Cost Structure

Figure 64. Channels of Distribution (Direct Sales, and Distribution)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Pet NSAIDs market? zhanKai

The top companies in the global Pet NSAIDs market are Zoetis、Elanco、PREVICOX.

What was the global market size of Pet NSAIDs in 2024? shouQi

Which region is expected to have the highest market share? shouQi

What is the annual compound growth rate of the global Pet NSAIDs market size from 2024 to 2030? shouQi

What was the global market size of Pet NSAIDs in 2030? shouQi

Related Reports

Global Pet NSAIDs Market Research Report 2025
The global market for Pet NSAIDs was valued at US$ 37.8 million in the year 2024 and is projected to reach a revised size of US$ 49.9 million by 2031, growing at a CAGR of 4.1% during the forecast period.
Published Date: 2025-01-01
Pages: 99
USD 2900.00
(Single User License)
Global Pet NSAIDs Market Research Report 2024
Pet Non-steroidal anti-inflammatory drugs (NSAIDs) are medicines that are widely used to relieve pain, reduce inflammation, and bring down a high temperature. They can relieve the pain caused by inflammation of the pet's knee joint.
Published Date: 2024-01-21
Pages: 103
USD 2900.00
(Single User License)

Global Pet NSAIDs Market Research Report 2025
The global market for Pet NSAIDs was valued at US$ 37.8 million in the year 2024 and is projected to reach a revised size of US$ 49.9 million by 2031, growing at a CAGR of 4.1% during the forecast period.
Published: 2025-01-01
Pages: 99
USD 2900.00 (Single User License)
Global Pet NSAIDs Market Research Report 2024
Pet Non-steroidal anti-inflammatory drugs (NSAIDs) are medicines that are widely used to relieve pain, reduce inflammation, and bring down a high temperature. They can relieve the pain caused by inflammation of the pet's knee joint.
Published: 2024-01-21
Pages: 103
USD 2900.00 (Single User License)